Portage Learning BIOD 102 Biology II Module 5 Exam LATEST

1




Module 5 Exam- Requires Respondus LockDown Browser



Question 1 pts


Multiple Choice:

Which of the following is concerned with the treatment of disease and
suffering?


Co
orrrec
ct! therapeutics


pharmaceutics


pharmacology


pharmacotherapies




Question 2 pts



Multiple Choice:




Portage LearningBIOD 102Biology II Module 5 Exam 1/18

, Vaccines, hormones, and insulin are examples of: 2



traditional drug therapies

Co
orrrec
ct! biologics


natural alternative therapies




Question 3 pts


Multiple Choice:

The goal of the preclinical phase is to determine which drugs are:


Co
orrrec
ct! not safe


safe


efficacious




Question 4 pts


Multiple Choice:

The clinical investigation stage of drug development is important for
determining each of the following except:


adverse effects

orrect Answer improvement of condition


worsening of other conditions



Portage LearningBIOD 102Biology II Module 5 Exam 2/18

, 3
ou An
nsw
werred gathering data from clinical trials




Question 5 pts


Multiple Choice:

During the NDA process, if there is a concern regarding safety or
effectiveness data, what will occur?


the process is permanently halted


the process is continued

Co
orrrec
ct! developers are given the opportunity for remediations


the process must begin again at pre-clinical studies




Question 6 pts


Multiple Choice:

During the post-marketing phase, focus remains on within the
general population.


Co
orrrec
ct! adverse events


profit margin


toxicity


none of the above




Portage LearningBIOD 102Biology II Module 5 Exam 3/18